Autoimmune Diseases  >>  GSK239512  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK239512 / GSK
NCT01802931: GSK239512 DDI Study

Completed
1
22
RoW
GSK239512, ketoconazole
GlaxoSmithKline
Multiple Sclerosis
04/13
04/13

Download Options